Marketplace News: May 2023
Philips Respironics has recalled a second set of CPAP/BiPAP machines, identified as a Class I recall by the U.S. Food and Drug Administration. The 1,088 recalled DreamStation1 units, distributed between […]
Source: ENT Today - Category: ENT & OMF Authors: Amy Hamaker Tags: Online Exclusives Otology/Neurotology Practice Focus Sleep Medicine Source Type: research
More News: Brain | ENT & OMF | Food and Drug Administration (FDA) | Neurology | Sleep Disorders | Sleep Medicine